DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2243528/here-s-why-you-should-hold-surmodics-srdx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2243528 Mar 20, 2024 - Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock. 0

https://www.zacks.com/stock/news/2243527/here-s-why-you-should-retain-accuray-aray-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2243527 Mar 20, 2024 - Accuray's (ARAY) solid product demand raises optimism about the stock. 0

https://www.zacks.com/stock/news/2243034/here-s-why-investors-should-retain-abbott-abt-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2243034 Mar 19, 2024 - Investors are optimistic about Abbott (ABT), led by solid prospects in the Diagnostic business and robust adoption of FreeStyle Libre. 0

https://www.zacks.com/stock/news/2243024/inspira-technologies-iinn-strives-to-get-amar-nod-for-art100?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2243024 Mar 19, 2024 - The AMAR submission is a strategic move by Inspira Technologies (IINN), positioning it to target global markets with its innovative Augmented Respiration Technology (INSPIRA ART). 0

https://www.zacks.com/stock/news/2242895/johnson-johnson-jnj-nvidia-unite-to-boost-ai-for-surgery?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2242895 Mar 19, 2024 - Johnson & Johnson (JNJ) collaborates with Nvidia to facilitate the creation of AI-based models and the deployment of applications, offering a route to scale within its digital ecosystem for surgery. 0

https://www.zacks.com/stock/news/2242869/here-s-why-you-should-retain-healthequity-hqy-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242869 Mar 19, 2024 - HealthEquity's (HQY) strength in HSAs raises optimism about the stock. 0

https://www.zacks.com/stock/news/2242630/here-s-why-you-should-retain-tandem-diabetes-tndm-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242630 Mar 19, 2024 - Product innovations and strategic progress bode well for Tandem Diabetes (TNDM). 0

https://www.zacks.com/stock/news/2242349/here-s-why-you-should-retain-inspire-medical-insp-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242349 Mar 18, 2024 - Inspire Medical's (INSP) focus on R&D raises optimism about the stock. 0

https://www.zacks.com/stock/news/2242295/revvity-s-rvty-new-launch-to-boost-newborn-sequencing-research?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2242295 Mar 18, 2024 - Revvity's (RVTY) next-generation newborn sequencing research workflow is likely to build the foundation for diagnosing rare diseases in the future. 0

https://www.zacks.com/stock/news/2242278/waters-wat-boosts-pfas-testing-solutions-with-new-cartridges?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2242278 Mar 18, 2024 - Waters (WAT) launches Oasis WAX/GCB and GCB/WAX Cartridges for PFAS testing, thus boosting the Waters Operating segment. 0